Abstract
The therapeutic efficacy of intermittent, monthly, postmenstrual prophylaxis with a single 500 mg clotrimazole vaginal tablet (n = 33) was compared with placebo tablets (n = 29) in 62 woman (age 28.1, SD 7.2 years) with recurrent vulvovaginal candidiasis. The number of episodes of acute vulvovaginal candidiasis experienced during the year prior to inclusion was 6.3, SD 1.9. The cumulative recurrence frequency after 6 months intermittent prophylaxis with clotrimazole (30.3%) was lower (p less than 0.001) than that recorded for the women who received placebo (79.3%). After an additional 6 months observation period without treatment there was no significant difference in the cumulative recurrence frequency between the groups (clotrimazole 84.9%; placebo 86.2%). The vagina was recolonised with Candida albicans in 70% of the women after 6 months prophylactic treatment with clotrimazole and in 86% of the women who had received placebo. Thus, this study has demonstrated that postmenstrual prophylactic treatment with a single 500 mg clotrimazole vaginal tablet, applied monthly, prevents recurrence of symptoms, although it does not eliminate yeasts from the vagina.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Berg A. O., Heidrich F. E., Fihn S. D., Bergman J. J., Wood R. W., Stamm W. E., Holmes K. K. Establishing the cause of genitourinary symptoms in women in a family practice. Comparison of clinical examination and comprehensive microbiology. JAMA. 1984 Feb 3;251(5):620–625. [PubMed] [Google Scholar]
- Bushell T. E., Evans E. G., Meaden J. D., Milne J. D., Warnock D. W. Intermittent local prophylaxis against recurrent vaginal candidosis. Genitourin Med. 1988 Oct;64(5):335–338. doi: 10.1136/sti.64.5.335. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cohen L. Single dose treatment of vaginal candidosis: comparison of clotrimazole and isoconazole. Br J Vener Dis. 1984 Feb;60(1):42–44. doi: 10.1136/sti.60.1.42. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Cramer D. W., Walker A. M., Schiff I. Statistical methods in evaluating the outcome of infertility therapy. Fertil Steril. 1979 Jul;32(1):80–86. [PubMed] [Google Scholar]
- Davidson F., Mould R. F. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis. 1978 Jun;54(3):176–183. doi: 10.1136/sti.54.3.176. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Forssman L., Milsom I. Treatment of recurrent vaginal candidiasis. Am J Obstet Gynecol. 1985 Aug 1;152(7 Pt 2):959–961. doi: 10.1016/s0002-9378(85)80010-7. [DOI] [PubMed] [Google Scholar]
- Hopwood V., Warnock D. W., Milne J. D., Crowley T., Horrocks C. T., Taylor P. K. Evaluation of a new slide latex agglutination test for diagnosis of vaginal candidosis. Eur J Clin Microbiol. 1987 Aug;6(4):392–394. doi: 10.1007/BF02013092. [DOI] [PubMed] [Google Scholar]
- Kalo-Klein A., Witkin S. S. Candida albicans: cellular immune system interactions during different stages of the menstrual cycle. Am J Obstet Gynecol. 1989 Nov;161(5):1132–1136. doi: 10.1016/0002-9378(89)90649-2. [DOI] [PubMed] [Google Scholar]
- Milsom I., Forssman L. Treatment of vaginal candidosis with a single 500-mg clotrimazole pessary. Br J Vener Dis. 1982 Apr;58(2):124–126. doi: 10.1136/sti.58.2.124. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sobel J. D. Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis. Obstet Gynecol. 1985 Mar;65(3):435–440. [PubMed] [Google Scholar]
- Sobel J. D., Schmitt C., Meriwether C. Clotrimazole treatment of recurrent and chronic candida vulvovaginitis. Obstet Gynecol. 1989 Mar;73(3 Pt 1):330–334. [PubMed] [Google Scholar]